Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3 Penny Stocks Robinhood Users Are Watching – October 2019
$TROV $NYMX $RRD
https://www.transparenttraders.me/2019/10/3-penny-stocks-robinhood-users-are.html
Director James G. Robinson now owns 3,510,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,503,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,496,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,487,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,479,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,470,550 Shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,460,550 shares
and keeps purchasing on the open market
Director James G. Robinson now owns 3,451,550 shares and keeps purchasing on the open market.
Director James G. Robinson now owns 3,443,550 shares and keeps purchasing on the open market.
Nymox End of Q2 New Investor Presentation on Website.
https://nymox.com/investors/company-presentation
Director James G. Robinson now owns 3,434,550 shares and keeps purchasing on the open market.
Director James G. Robinson now owns 3,425,550 shares and keeps purchasing on the open market.
NYMX may have a cure for Prostate cancer.
NYMX getting close to filing NDA
Hello *** anything new you can add about the Company , I see more Buying by Large Inside Holder's, anything you can add will be helpful, Thank You.
News: $NYMX Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
HASBROUCK HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of Quality and EU Qualified Person, for all of Nymox's Chemistry, Manufacturing a...
Got this from https://marketwirenews.com/news-releases/nymox-announces-appointment-of-russell-thomson-ph-d-as-director-of-quality-and-eu-qualified-person-for-company-s-manufacturing-operations-7834450.html
Does anyone have any ideas on the insider trades?
Why does George Robinson buy shares almost weekly?
Why did CEO Paul Averback sell nearly 2,000,000 shares at the lowest price in over a year? Any thoughts? Thanks
This is going to go up quite a bit from this news. I would say $5 by EOD.
Nice update today.......I’m loaded with options JAN 19 $3 calls
2018 will finally be the year!
A very bullish sign!!!!
Warrants at $8.00!!!!!
To the east side ??????
Thank you Stan for a great Seeking Alpha article yesterday.
Okay, so maybe I do care. STOP GOING DOWN!
I don’t care what the stock price is right now. I’m going to put my GTC sell order in for $100 and wait for the trade conformation.
We may get this approved by end of year.
It will start with the approuval in Europe and follow up with a partner or buyout!
It's bee a long slow ride, someday soon there will be great news.
* * $NYMX Video Chart 01-22-18 * *
Link to Video - click here to watch the technical chart video
I smell something brewing!
2018 will be a big year for Nymox.
NOTICE OF THE ANNUAL GENERAL MEETING OF THE SHAREHOLDERS
NOTICE IS HEREBY GIVEN that the Annual General Meeting of the shareholders (the “Meeting”) of Nymox Pharmaceutical Corporation (the “Corporation”) will be held at the British Colonial Hilton, Nassau Bahamas, Number One Bay St., Nassau Bahamas, on Tuesday, December 19, 2017, at 4:30 p.m. (EDT), for the following purposes:
1.
to receive the annual report of the directors, the financial statements of the Corporation for the fiscal year ended December 31, 2016 and the auditors' report thereon;
2.
to elect the directors of the Corporation;
3.
to appoint the auditors of the Corporation and to authorize the Board of Directors to fix their remuneration;
4.
to ratify the acts of the members of the Board of Directors for the fiscal year ending 2016; and, up and to the date of this meeting;
5.
to transact such other matters as may properly be brought before the Meeting, or any adjournment thereof.
All shareholders are invited to attend the Meeting.
By order of the Board of Directors,
Paul Averback MD CEO & President
November 28, 2017 Nassau, The Bahamas
Current outstanding shares.
As at November 29, 2017, 54,831,565 common shares without par value of the Corporation were outstanding.
Insider holdings.
Paul Averback, M.D., D.A.B.P. Nassau, Bahamas (4)
CEO, President, and Chairman
Sept. 20, 1995
President of the Corporation
21,151,448 (37%)
As trustee 607,031* (1.1%)
Randall Lanham, Esq. Rancho Santa Margarita, USA
Director
June 8, 2006
Attorney– Corporate mergers and acquisitions
50,000 (.0009%)
James G. Robinson, Baltimore, MD, USA
Director
July 1, 2015
Business
Executive
2,750,000 (5.01%)
Richard Cutler, Esq. Director
Director
396 (0.001%)
Big news coming next month. James Robinson now has over 3 million shares.
Another promising prostate cancer stock, obmp , and just release good news. MC is less than 20 millions. Check it.
SO DO I :) EXTREMELY BULLISH!!! THIS IS A BLOCKBUSTER DRUG - WHEN APPROVALS START TO ROLL IN, BPH SUFFERING WITH ROLL OUT - AND ITS ABILITY TO VIRTUALLY DESTROY PROSTATE CANCER IS JUST ANOTHER SUPERPOWER OF THIS DRUG!!! SOOOOO CHEAP RIGHT NOW - WRITE THIS DOWN - "NYMOX IS THE NEXT JAZZ!!!"
Here we go again!
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1137
|
Created
|
05/14/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |